← Eichor
Study identifier: NCT05996172 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Swift Outpatient Alternatives for Rapid Stabilization

Condition: Suicidal Ideation · Suicide Attempt  ·  Sponsor: University of Washington

PhaseNA
Planned participants184
Who can joinAll sexes, 13 Years to 21 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to improve the effective outpatient management of acute youth suicide risk by optimizing intervention components to build an efficient, evidence-based intervention that is responsive to the needs of, and coordinated with, providers in primary care settings. The main questions are: 1. What is the strongest combination of SOARS components associated with reduction in youth suicidal thoughts and behavior (STB)? 2. Do age and STB history moderate the impact of the effects of the SOARS intervention components? 3. Do therapeutic alliance, youth and caregiver self-efficacy account for changes in youth STBs? 4. What helps medical outpatient providers refer to SOARS and continue care after SOARS?

This description comes directly from the study's public registry record.

Talk to the study team

Molly Adrian  ·  206-987-7183  ·  molly.adrian@seattlechildrens.org

Always discuss trial participation with your own doctor first.

Locations (1)

Seattle Children'sSeattle, Washington, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05996172